Who Paid My Doc
DaTscan
Drug Pharma Imaging Agents - Nuclear Imaging
NDC 17156-210-01
General payments
$28,969
Research payments
$166,948
Through program year 2025, $28,969 in general payments and $166,948 in research payments were reported against DaTscan (Pharma Imaging Agents - Nuclear Imaging).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $6,000 | 1 |
| 2025 | Research | $93,406 | 6 |
| 2024 | General | $18,439 | 10 |
| 2024 | Research | $73,542 | 11 |
| 2023 | General | $4,530 | 4 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
15 general · 17 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.